Innovative Administration Systems for Vaccines

Doubletree Hotel
Rockville, Maryland
December 18-19, 2003

Please note that documents in PDF format require Adobe's Acrobat Reader

Microsoft PowerPoint files are included for any presentation containing a video. Videos may only be viewed in the PowerPoint version, not in the PDF version.

The sole purpose of this website is to provide attendees of the Innovative Administration Systems for Vaccines Meeting, held December 18-19, 2003, in Rockville, Maryland, with an electronic account of the research presented. The website contains unedited information as provided by the speakers; any use of the information should be coordinated with them. Responsibility for the content rests solely with the speakers and not with the Government or SAIC. Questions may be directed to the speakers; contact information appears in the List of Attendees.

Letter from the Meeting Chair

Technical Program Committee

Science Applications International Corporation - Meeting Support Staff

Exhibitors

Agenda

Speaker Presentations

1. Keynote Address: A Needle-Free Vision, M. Levine
2. Mainstreaming New Immunization Technologies, J. Lloyd
3. Grand Challenges in Global Health: Vaccine Priorities, C. Dahl
4. Cutaneous or Mucosal Delivery of Anthrax rPA Provides Protection against Inhalational Anthrax, J. Mikszta (PDF, PowerPoint)
5. Epidermal Powder Immunization, D. Chen
6. Completely Stable Liquid Vaccines and Disposable Safety Injectors, B. Roser
7. Transcutaneous Immunization: Vaccines Delivered Via a Patch, G. Glenn
8. Overview and Challenges for Mass Vaccination with Jet Injectors (JIs), B. Weniger
9. Solving the Problems of Mass Vaccination with Needle-Free Technology, M. Mathews
10. Safety Evaluation of Re-designed Multi-Use-Nozzle Jet Injectors, M. Friede
11. Feedback from the Field: Needle-Free Injection Use in Large Scale Immunization Campaigns, K. Lynam
12. LectraJet® HS – Needle-Free Injection System for Routine Immunization and Mass Immunization Campaigns, L. D’Antonio (PDF, PowerPoint)
13. PATH’s Experience from Jet Injector R&D and Field Assessment in Developing Countries, D. Zehrung (PDF, PowerPoint (requires QuickTime Player, available at www.apple.com/quicktime/))
14. Roadmap Toward an International Standard for Prefillable, Disposable Jet Injection Cartridges, M. Friede
15. Panel Discussion: Regulation of Combination Products, M. Kramer (Handout- Background on Regulation of Combination Products)
16. FluMist Delivery System – The First Nasal Vaccine in the U.S., J. Young
17. The OptiNose Bi-directional Nasal Delivery Devices for Vaccines, P. Djupesland
18. Measles Vaccination by Aerosol, M. Papania
19. Live Bacterial Vectors, C. Tacket
20. Targeted Delivery of Mucosal Vaccines, D. Lo
21. Mucosal Immunization against Plague and Anthrax Using Microparticles, J. Eyles
22. Bacterial Ghosts as Carrier and Targeting Systems for Mucosal Antigen Delivery, W. Lubitz
23. VEE Replicon Vaccines in Development, J. Smith
24. Delivery of Plant-Derived Oral Vaccines, C. Arntzen
25. Pluronic® F127-Based Systemic and Mucosal Vaccine Delivery Systems, C. Coeshott
26. Novel Biopolymers for Controlled Release, A. Ficht
27. Proteosome™ Adjuvants for Nasal Vaccines against Influenza and Plague, L. Fries
28. Cochleates: A Formulation and Delivery Platform Technology, R. Mannino
29. Phage T4 Display for Vaccine Delivery, M. Rao
30. Panel Discussion: Promises and Challenges for Mucosal Delivery Systems, D. Kopecko

List of Attendees

References

HHS Home | Questions? | Contact HHS | Accessibility | Privacy Policy | FOIA | Disclaimers

The White House | USA.gov | Helping America's Youth

U.S. Department of Health & Human Services · 200 Independence Avenue, S.W. · Washington, D.C. 20201